Correlation Between Tscan Therapeutics and Everest

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Everest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Everest into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Everest Group, you can compare the effects of market volatilities on Tscan Therapeutics and Everest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Everest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Everest.

Diversification Opportunities for Tscan Therapeutics and Everest

0.25

Correlation Coefficient

Tscan Therapeutics  Everest

Modest diversification

The 3 months correlation between Tscan and Everest is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Everest Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Everest Group and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Everest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Everest Group has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Everest go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Everest

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Everest. In addition to that, Tscan Therapeutics is 3.23 times more volatile than Everest Group. It trades about -0.26 of its total potential returns per unit of risk. Everest Group is currently generating about 0.02 per unit of volatility. If you would invest  35,794  in Everest Group on December 27, 2024 and sell it today you would earn a total of  431.00  from holding Everest Group or generate 1.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Everest Group

Tscan Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Everest Group

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Everest Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Everest is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Tscan Therapeutics and Everest

The main advantage of trading using opposite Tscan Therapeutics and Everest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Everest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Everest will offset losses from the drop in Everest's long position.

The idea behind Tscan Therapeutics and Everest Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.